Quit a GLP-1? Plan to start again? It's not recommended, but plenty of people do it
Yuki NoguchiNPR News
A majority of people who start the obesity and diabetes medicines known as GLP-1s also quit them, and plan to restart again. Research hasn't yet shown the health impacts of cycling on and off the drugs. (Image credit: JoNel Aleccia)
A majority of people who start the obesity and diabetes medicines known as GLP-1s also quit them, and plan to restart again. Research hasn't yet shown the health impacts of cycling on and off the drugs.
(Image credit: JoNel Aleccia)
Reported by NPR NewsRead original
Coverage from 1 source
Coverage by lean
- Unknown1
Comments
Loading comments…
Sign in to join the discussion.
Sign in with SpryLogin